At a glance
- Originator Dong-A Pharmaceutical
- Class Antibacterials; Oxazolidinones; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gram-positive infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Gram-positive-infections in Japan
- 04 Nov 2017 No recent reports of development identified for preclinical development in Gram-positive-infections in USA
- 20 May 2004 A preclinical study has been added to the Bacterial Infections antimicrobial activity section